Literature DB >> 29976567

T1-REDEEM: A Randomized Controlled Trial to Reduce Diabetes Distress Among Adults With Type 1 Diabetes.

Lawrence Fisher1, Danielle Hessler2, William H Polonsky3, Umesh Masharani2, Susan Guzman4, Vicky Bowyer2, Lisa Strycker5, Andrew Ahmann6, Marina Basina7, Ian Blumer8, Charles Chloe9, Sarah Kim2, Anne L Peters10, Martha Shumway2, Karen Weihs11, Patricia Wu12.   

Abstract

OBJECTIVE: To compare the effectiveness of two interventions to reduce diabetes distress (DD) and improve glycemic control among adults with type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS: Individuals with T1D (n = 301) with elevated DD and HbA1c were recruited from multiple settings and randomly assigned to OnTrack, an emotion-focused intervention, or to KnowIt, an educational/behavioral intervention. Each group attended a full-day workshop plus four online meetings over 3 months. Assessments occurred at baseline and 3 and 9 months. Primary and secondary outcomes were change in DD and change in HbA1c, respectively.
RESULTS: With 12% attrition, both groups demonstrated dramatic reductions in DD (effect size d = 1.06; 78.4% demonstrated a reduction of at least one minimal clinically important difference). There were, however, no significant differences in DD reduction between OnTrack and KnowIt. Moderator analyses indicated that OnTrack provided greater DD reduction to those with initially poorer cognitive or emotion regulation skills, higher baseline DD, or greater initial diabetes knowledge than those in KnowIt. Significant but modest reductions in HbA1c occurred with no between-group differences. Change in DD was modestly associated with change in HbA1c (r = 0.14, P = 0.01), with no significant between-group differences.
CONCLUSIONS: DD can be successfully reduced among distressed individuals with T1D with elevated HbA1c using both education/behavioral and emotion-focused approaches. Reductions in DD are only modestly associated with reductions in HbA1c. These findings point to the importance of tailoring interventions to address affective, knowledge, and cognitive skills when intervening to reduce DD and improve glycemic control.
© 2018 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29976567      PMCID: PMC6105321          DOI: 10.2337/dc18-0391

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  23 in total

1.  AASAP: a program to increase recruitment and retention in clinical trials.

Authors:  Lawrence Fisher; Danielle Hessler; Diana Naranjo; William Polonsky
Journal:  Patient Educ Couns       Date:  2011-08-09

2.  Using self-report assessment methods to explore facets of mindfulness.

Authors:  Ruth A Baer; Gregory T Smith; Jaclyn Hopkins; Jennifer Krietemeyer; Leslie Toney
Journal:  Assessment       Date:  2006-03

3.  Association of diabetes-related emotional distress with diabetes treatment in primary care patients with Type 2 diabetes.

Authors:  L M Delahanty; R W Grant; E Wittenberg; J L Bosch; D J Wexler; E Cagliero; J B Meigs
Journal:  Diabet Med       Date:  2007-01       Impact factor: 4.359

4.  Emotion regulation contributes to the development of diabetes distress among adults with type 1 diabetes.

Authors:  Lawrence Fisher; Danielle Hessler; William Polonsky; Lisa Strycker; Susan Guzman; Vicky Bowyer; Ian Blumer; Umesh Masharani
Journal:  Patient Educ Couns       Date:  2017-07-08

Review 5.  The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision.

Authors:  L Fisher; J S Gonzalez; W H Polonsky
Journal:  Diabet Med       Date:  2014-07       Impact factor: 4.359

Review 6.  Annual Research Review: On the relations among self-regulation, self-control, executive functioning, effortful control, cognitive control, impulsivity, risk-taking, and inhibition for developmental psychopathology.

Authors:  Joel T Nigg
Journal:  J Child Psychol Psychiatry       Date:  2016-12-30       Impact factor: 8.982

7.  Understanding the sources of diabetes distress in adults with type 1 diabetes.

Authors:  Lawrence Fisher; William H Polonsky; Danielle M Hessler; Umesh Masharani; Ian Blumer; Anne L Peters; Lisa A Strycker; Vicky Bowyer
Journal:  J Diabetes Complications       Date:  2015-02-07       Impact factor: 2.852

8.  When is diabetes distress clinically meaningful?: establishing cut points for the Diabetes Distress Scale.

Authors:  Lawrence Fisher; Danielle M Hessler; William H Polonsky; Joseph Mullan
Journal:  Diabetes Care       Date:  2012-01-06       Impact factor: 19.112

9.  Reductions in regimen distress are associated with improved management and glycemic control over time.

Authors:  Danielle Hessler; Lawrence Fisher; Russell E Glasgow; Lisa A Strycker; L Miriam Dickinson; Patricia A Arean; Umesh Masharani
Journal:  Diabetes Care       Date:  2013-10-29       Impact factor: 19.112

10.  REDEEM: a pragmatic trial to reduce diabetes distress.

Authors:  Lawrence Fisher; Danielle Hessler; Russell E Glasgow; Patricia A Arean; Umesh Masharani; Diana Naranjo; Lisa A Strycker
Journal:  Diabetes Care       Date:  2013-06-04       Impact factor: 19.112

View more
  23 in total

Review 1.  How Do the Challenges of Emerging Adulthood Inform our Understanding of Diabetes Distress? An Integrative Review.

Authors:  Katherine Wentzell; Judith A Vessey; Lori M B Laffel
Journal:  Curr Diab Rep       Date:  2020-04-23       Impact factor: 4.810

2.  Physical symptom complaints, cognitive emotion regulation strategies, self-compassion and diabetes distress among adults with Type 2 diabetes.

Authors:  N S Kane; C J Hoogendoorn; M L Tanenbaum; J S Gonzalez
Journal:  Diabet Med       Date:  2018-10-25       Impact factor: 4.359

3.  Diabetes Distress, Depressive Symptoms, and Cardiovascular Health in Adults With Type 1 Diabetes.

Authors:  Margaret M McCarthy; Robin Whittemore; Georica Gholson; Margaret Grey
Journal:  Nurs Res       Date:  2019 Nov/Dec       Impact factor: 2.381

4.  Economic costs of implementing group interventions to reduce diabetes distress in adults with type 1 diabetes mellitus in the T1-REDEEM trial.

Authors:  Martha Shumway; Lawrence Fisher; Danielle Hessler; Vicky Bowyer; William H Polonsky; Umesh Masharani
Journal:  J Diabetes Complications       Date:  2019-08-15       Impact factor: 2.852

5.  Coping skills and glycaemic control: the mediating role of diabetes distress.

Authors:  Christine Y K Lau; Alice P S Kong; Joseph T F Lau; Virginia Chan; Phoenix K H Mo
Journal:  Acta Diabetol       Date:  2021-03-25       Impact factor: 4.280

6.  Toward effective interventions to reduce diabetes distress among adults with type 1 diabetes: Enhancing Emotion regulation and cognitive skills.

Authors:  Lawrence Fisher; Danielle Hessler; William Polonsky; Lisa Strycker; Vicky Bowyer; Umesh Masharani
Journal:  Patient Educ Couns       Date:  2019-03-27

7.  Does Diabetes Distress Influence Clinical Response to an mHealth Diabetes Self-Management Education and Support Intervention?

Authors:  Taylor L Clark; Linda Gallo; Johanna A Euyoque; Athena Philis-Tsimikas; Addie Fortmann
Journal:  Diabetes Educ       Date:  2020-03-31       Impact factor: 2.140

Review 8.  Chronic Care Management Services for Complex Diabetes Management: a Practical Overview.

Authors:  Kayla L Del Valle; Marie E McDonnell
Journal:  Curr Diab Rep       Date:  2018-10-20       Impact factor: 4.810

Review 9.  Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field.

Authors:  Gregory P Forlenza; Laurel H Messer; Cari Berget; R Paul Wadwa; Kimberly A Driscoll
Journal:  Curr Diab Rep       Date:  2018-09-26       Impact factor: 4.810

Review 10.  Social Media in the Diabetes Community: a Novel Way to Assess Psychosocial Needs in People with Diabetes and Their Caregivers.

Authors:  Tamara K Oser; Sean M Oser; Jessica A Parascando; Danielle Hessler-Jones; Christopher N Sciamanna; Kerri Sparling; Donald Nease; Michelle L Litchman
Journal:  Curr Diab Rep       Date:  2020-02-20       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.